Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ)
CNY 3.4
(-0.58%)
CNY 3.4
(-0.58%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 385.03 Million CNY | -6.93% |
| 2022 | 427.81 Million CNY | -5.25% |
| 2021 | 451.51 Million CNY | 5.03% |
| 2020 | 429.9 Million CNY | -18.36% |
| 2019 | 526.56 Million CNY | 144.05% |
| 2018 | -1.19 Billion CNY | -382.98% |
| 2017 | 422.41 Million CNY | 82.72% |
| 2016 | 231.18 Million CNY | 25.36% |
| 2015 | 184.41 Million CNY | 5.35% |
| 2014 | 175.05 Million CNY | 366.96% |
| 2013 | 37.48 Million CNY | -18.27% |
| 2012 | 45.87 Million CNY | -5.61% |
| 2011 | 48.59 Million CNY | 24.86% |
| 2010 | 38.91 Million CNY | -26.92% |
| 2009 | 53.25 Million CNY | 61.78% |
| 2008 | 32.91 Million CNY | 17.25% |
| 2007 | 28.07 Million CNY | 32.7% |
| 2006 | 21.15 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 87.16 Million CNY | 3.13% |
| 2024 Q3 | 101.3 Million CNY | 16.23% |
| 2024 Q1 | 84.51 Million CNY | 123.37% |
| 2023 Q2 | 137.64 Million CNY | 93.53% |
| 2023 Q3 | 131.08 Million CNY | -4.76% |
| 2023 FY | 398.18 Million CNY | -6.93% |
| 2023 Q4 | 37.83 Million CNY | -71.14% |
| 2023 Q1 | 71.12 Million CNY | 959.04% |
| 2022 Q1 | 89.02 Million CNY | -40.68% |
| 2022 FY | 427.81 Million CNY | -5.25% |
| 2022 Q4 | 6.71 Million CNY | -95.22% |
| 2022 Q3 | 140.42 Million CNY | 31.09% |
| 2022 Q2 | 107.11 Million CNY | 20.32% |
| 2021 Q1 | 94.29 Million CNY | -1.99% |
| 2021 Q3 | 121.47 Million CNY | 41.82% |
| 2021 Q4 | 150.08 Million CNY | 23.55% |
| 2021 FY | 451.51 Million CNY | 5.03% |
| 2021 Q2 | 85.65 Million CNY | -9.16% |
| 2020 Q1 | -33.11 Million CNY | -139.36% |
| 2020 Q4 | 96.21 Million CNY | -32.7% |
| 2020 FY | 429.9 Million CNY | -18.36% |
| 2020 Q3 | 142.95 Million CNY | 75.72% |
| 2020 Q2 | 81.35 Million CNY | 345.64% |
| 2019 Q1 | 65.17 Million CNY | 104.29% |
| 2019 Q4 | 84.15 Million CNY | -20.62% |
| 2019 Q2 | 89.66 Million CNY | 37.57% |
| 2019 Q3 | 106.01 Million CNY | 18.24% |
| 2019 FY | 526.56 Million CNY | 144.05% |
| 2018 Q4 | -1.51 Billion CNY | -1743.68% |
| 2018 Q3 | 92.4 Million CNY | -37.48% |
| 2018 Q2 | 147.8 Million CNY | 77.57% |
| 2018 FY | -1.19 Billion CNY | -382.98% |
| 2018 Q1 | 83.23 Million CNY | -25.72% |
| 2017 Q3 | 131.42 Million CNY | -8.76% |
| 2017 Q2 | 144.04 Million CNY | 312.93% |
| 2017 FY | 422.41 Million CNY | 82.72% |
| 2017 Q1 | 34.88 Million CNY | 90.54% |
| 2017 Q4 | 112.06 Million CNY | -14.73% |
| 2016 FY | 231.18 Million CNY | 25.36% |
| 2016 Q2 | 89.62 Million CNY | 90.14% |
| 2016 Q3 | 76.11 Million CNY | -15.07% |
| 2016 Q4 | 18.3 Million CNY | -75.95% |
| 2016 Q1 | 47.13 Million CNY | 73.83% |
| 2015 FY | 184.41 Million CNY | 5.35% |
| 2015 Q2 | 61.37 Million CNY | 57.77% |
| 2015 Q1 | 38.9 Million CNY | -45.59% |
| 2015 Q4 | 27.11 Million CNY | -52.45% |
| 2015 Q3 | 57.02 Million CNY | -7.09% |
| 2014 Q2 | 48.55 Million CNY | 1160.18% |
| 2014 Q1 | 3.85 Million CNY | -54.04% |
| 2014 Q3 | 51.14 Million CNY | 5.35% |
| 2014 FY | 175.05 Million CNY | 366.96% |
| 2014 Q4 | 71.49 Million CNY | 39.78% |
| 2013 Q1 | 6.24 Million CNY | -42.98% |
| 2013 Q2 | 13.54 Million CNY | 116.66% |
| 2013 Q3 | 9.31 Million CNY | -31.21% |
| 2013 Q4 | 8.38 Million CNY | -10.01% |
| 2013 FY | 37.48 Million CNY | -18.27% |
| 2012 FY | 45.87 Million CNY | -5.61% |
| 2012 Q1 | 7.44 Million CNY | -43.57% |
| 2012 Q2 | 17.86 Million CNY | 139.96% |
| 2012 Q3 | 9.6 Million CNY | -46.23% |
| 2012 Q4 | 10.96 Million CNY | 14.12% |
| 2011 Q3 | 9.43 Million CNY | -50.08% |
| 2011 Q2 | 18.9 Million CNY | 167.66% |
| 2011 Q1 | 7.06 Million CNY | -21.12% |
| 2011 FY | 48.59 Million CNY | 24.86% |
| 2011 Q4 | 13.19 Million CNY | 39.77% |
| 2010 Q1 | 7.29 Million CNY | -65.1% |
| 2010 Q2 | 13.97 Million CNY | 91.43% |
| 2010 FY | 38.91 Million CNY | -26.92% |
| 2010 Q4 | 8.95 Million CNY | 2.97% |
| 2010 Q3 | 8.69 Million CNY | -37.76% |
| 2009 FY | 53.25 Million CNY | 61.78% |
| 2009 Q1 | 5.63 Million CNY | 0.0% |
| 2009 Q2 | 14.2 Million CNY | 152.35% |
| 2009 Q4 | 20.91 Million CNY | 61.05% |
| 2009 Q3 | 12.98 Million CNY | -8.62% |
| 2008 FY | 32.91 Million CNY | 17.25% |
| 2007 FY | 28.07 Million CNY | 32.7% |
| 2006 FY | 21.15 Million CNY | 0.0% |